Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 3.7B | 3.7B | 3.6B | 3.2B |
Cost of revenue | 2.4B | 2.5B | 2.3B | 2.0B |
Gross profit | 1.3B | 1.2B | 1.3B | 1.2B |
Operating expense | ||||
Research & development | 151.1M | 148.9M | 143.3M | 135.0M |
Selling general and admin | 559.6M | 526.9M | 567.9M | 507.4M |
Other operating expenses | — | — | — | — |
Operating income | 563.4M | 531.5M | 637.0M | 554.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2.6M | 4.5M | — | 3.9M |
Other income expense | -130.4M | -145.2M | -352.4M | -295.4M |
Pretax income | 430.4M | 381.7M | 286.6M | 255.0M |
Tax provision | 67.6M | 72.2M | 60.0M | 53.4M |
Net income | 362.7M | 309.6M | 226.5M | 201.6M |
Basic EPS | — | 1.9 | 1.4 | 1.2 |
Diluted EPS | — | 1.8 | 1.4 | 1.2 |
Basic average shares | — | 1.2B | 1.2B | 1.2B |
Diluted average shares | — | 1.2B | 1.2B | 1.2B |
EBITDA | 577.1M | 539.9M | 1.0B | 574.8M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |